ECO2024: Tailoring and Tapering Obesity Medicines
May 12, 2024 — A pair of studies with semaglutide at ECO2024 in Venice goes straight to the heart of some core questions about advanced obesity medicines. Does everyone need the full, maximum dose to get good results? Will everyone have to keep taking that full dose to keep obesity under control? The answer to both questions is no. […]
